Glaxosmithkline Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLAXO
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 57,396 Cr.

52 Week - High/Low ₹ 3,516/1,921

P/E Ratio 63.40

P/B Ratio 29.89

Enterprise Value ₹ 56,978 Cr.

ROE % 48.92

RSI Value 60.62

EMA 50 3115.42

EMA 200 2713.03

Market Cap. ₹ 57,396 Cr.

52 Week - High/Low ₹ 3,516/1,921

P/E Ratio 62.82

P/B Ratio 29.86

Enterprise Value ₹ 56,976 Cr.

ROE % 49.43

RSI Value 60.62

EMA 50 3115.42

EMA 200 2713.03

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us